Stromal control of oncogenic traits expressed in response to the overexpression of GLI2, a pleiotropic oncogene

A. M. Snijders, B. Huey, S. T. Connelly, R. Roy, R. C.K. Jordan, B. L. Schmidt, D. G. Albertson

Research output: Contribution to journalArticle

Abstract

Hedgehog signaling is often activated in tumors, yet it remains unclear how GLI2, a transcription factor activated by this pathway, acts as an oncogene. We show that GLI2 is a pleiotropic oncogene. The overexpression induces genomic instability and blocks differentiation, likely mediated in part by enhanced expression of the stem cell gene SOX2. GLI2 also induces transforming growth factor (TGF)B1-dependent transdifferentiation of foreskin and tongue, but not gingival fibroblasts into myofibroblasts, creating an environment permissive for invasion by keratinocytes, which are in various stages of differentiation having downregulated GLI2. Thus, upregulated GLI2 expression is sufficient to induce a number of the acquired characteristics of tumor cells; however, the stroma, in a tissue-specific manner, determines whether certain GLI2 oncogenic traits are expressed.

Original languageEnglish (US)
Pages (from-to)625-637
Number of pages13
JournalOncogene
Volume28
Issue number5
DOIs
StatePublished - Feb 5 2009

Keywords

  • GLI2
  • Invasion
  • Organotypic culture
  • Transdifferentiation

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Fingerprint Dive into the research topics of 'Stromal control of oncogenic traits expressed in response to the overexpression of GLI2, a pleiotropic oncogene'. Together they form a unique fingerprint.

  • Cite this